Summary

The global hospital acquired infection (HAI) control market is undergoing significant transformation due to increased focus on healthcare hygiene and patient safety. According to Fairfield Market Research, the market is projected to grow from USD 7.3 billion in 2025 to USD 9.7 billion by the end of 2032, reflecting a CAGR of 4.14% during the forecast period. Rising infection rates, especially post-COVID-19, and technological advancements in sterilization and disinfection equipment are key drivers shaping this market’s growth trajectory.

Market Insights

Hospital-acquired infections continue to pose a major risk to patients, with medical facilities focusing more on implementing effective control strategies. The demand for disinfection and sterilization technologies has risen sharply due to increasing awareness about the consequences of HAIs, along with strict government mandates aimed at improving hygiene standards across hospitals and clinics.

One of the primary reasons for market growth is the growing number of surgical procedures, which increase the risk of infection. In tandem with this, rising chronic illness prevalence and aging populations are necessitating longer hospital stays, further amplifying the need for robust infection control solutions.

Drivers

Several factors are propelling the expansion of the hospital acquired infection control market:

• Increased Surgical Interventions: A growing volume of surgeries has led to heightened demand for infection prevention protocols and equipment.

• Government Initiatives: Public health authorities across the globe have launched campaigns and funding programs to improve hospital hygiene and prevent HAIs.

• Awareness & Education: Rising awareness among healthcare professionals and patients about the benefits of proper sterilization and hygiene practices is reinforcing market demand.

• Technological Advancements: The introduction of automated and smart disinfection systems, such as UV-based and cloud-connected equipment, is revolutionizing infection control procedures.

Business Opportunity

The post-pandemic era has significantly amplified awareness and investment in infection control infrastructure. This has created fresh opportunities for manufacturers of sterilization and disinfection devices. Companies introducing portable, quick, and cloud-based sterilization solutions are likely to witness strong adoption across hospital and outpatient settings.

Furthermore, the growing preference for outpatient services and minimally invasive procedures supports the expansion of infection control systems in ambulatory surgical centers and clinics. As hygiene standards become more stringent, even small-scale diagnostic laboratories are expected to invest in advanced infection control systems.

Region Analysis

• United States: With a highly advanced healthcare system and substantial investments in medical infrastructure, the U.S. remains a dominant player, driven by a high incidence of HAIs and strong awareness levels.

• China: The country is emerging as a fast-growing market due to increased government spending on healthcare and efforts to reduce HAI rates. Ventilator-associated and hospital-acquired pneumonia remain major concerns.

• India: Ongoing healthcare reforms, infrastructure development, and growing public awareness are making India a lucrative destination for infection control equipment providers.

• Europe: A mature healthcare sector and well-established hygiene protocols continue to support consistent market performance across major EU countries.

Key Players

The market Analysis is characterized by intense competition and innovation, with several companies pursuing strategic initiatives to expand their global footprint. Notable developments include:

• PURioLABS launched a portable disinfection cabinet designed to rapidly sterilize frequently used instruments.

• Unimech Healthcare unveiled the UniClean series with UVGI and cloud connectivity to support scalable disinfection.

• STERIS plc acquired Cantel Medical to strengthen its infection control offerings across various medical verticals.

• UVision360 Inc. received approval for expanded reprocessing with its LUMINELLE DTx System.

Major players include Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, Bayer AG, Alere Inc., The 3M Company, Cepheid Inc., and UVision360 Inc.

Segmentation

By Product

• Heat Sterilization Equipment

o Moist Heat Sterilization Equipment

o Dry Heat Sterilization Equipment

• Low-Temperature Sterilization Equipment

• Radiation Sterilization Equipment

• Disinfection Equipment

o Disinfector

§ Washer Disinfector

§ Flusher Disinfector

o Endoscopic Reprocessor Systems

§ Single Basin

§ Dual Basin

o Disinfectants

By End User

• Hospitals

• Ambulatory Surgical Centres

• Medical Institutions

• Diagnostic Laboratories

• Clinics

By Region

• North America

• Latin America

• Europe

• South Asia

• East Asia

• Oceania

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Hospital Acquired Infection Control Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Hospital Acquired Infection Control Market Outlook, 2019-2032
3.1. Global Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Heat Sterilization Equipment
3.1.1.1.1. Moist Heat Sterilization Equipment
3.1.1.1.2. Dry Heat Sterilization Equipment
3.1.1.2. Low-Temperature Sterilization Equipment
3.1.1.3. Radiation Sterilization Equipment
3.1.1.4. Disinfection Equipment
3.1.1.4.1. Disinfector
3.1.1.4.1.1. Disinfector
3.1.1.4.1.1.1. Washer Disinfector
3.1.1.4.1.1.2. Flusher Disinfector
3.1.1.4.2. Flusher Disinfector
3.1.1.5. Endoscopic Reprocessor Systems
3.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
3.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
3.1.1.6. Disinfectants
3.2. Global Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Ambulatory Surgical Centres
3.2.1.3. Medical Institutions
3.2.1.4. Diagnostic Laboratories
3.2.1.5. Clinics
3.3. Global Hospital Acquired Infection Control Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2032
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Hospital Acquired Infection Control Market Outlook, 2019-2032
4.1. North America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Heat Sterilization Equipment
4.1.1.1.1. Moist Heat Sterilization Equipment
4.1.1.1.2. Dry Heat Sterilization Equipment
4.1.1.2. Low-Temperature Sterilization Equipment
4.1.1.3. Radiation Sterilization Equipment
4.1.1.4. Disinfection Equipment
4.1.1.4.1. Disinfector
4.1.1.4.1.1. Disinfector
4.1.1.4.1.1.1. Washer Disinfector
4.1.1.4.1.1.2. Flusher Disinfector
4.1.1.4.2. Flusher Disinfector
4.1.1.5. Endoscopic Reprocessor Systems
4.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
4.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
4.1.1.6. Disinfectants
4.2. North America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Ambulatory Surgical Centres
4.2.1.3. Medical Institutions
4.2.1.4. Diagnostic Laboratories
4.2.1.5. Clinics
4.3. North America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1. Key Highlights
4.3.1.1. U.S. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1.2. U.S. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1.3. Canada Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1.4. Canada Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Hospital Acquired Infection Control Market Outlook, 2019-2032
5.1. Europe Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Heat Sterilization Equipment
5.1.1.1.1. Moist Heat Sterilization Equipment
5.1.1.1.2. Dry Heat Sterilization Equipment
5.1.1.2. Low-Temperature Sterilization Equipment
5.1.1.3. Radiation Sterilization Equipment
5.1.1.4. Disinfection Equipment
5.1.1.4.1. Disinfector
5.1.1.4.1.1. Disinfector
5.1.1.4.1.1.1. Washer Disinfector
5.1.1.4.1.1.2. Flusher Disinfector
5.1.1.4.2. Flusher Disinfector
5.1.1.5. Endoscopic Reprocessor Systems
5.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
5.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
5.1.1.6. Disinfectants
5.2. Europe Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Ambulatory Surgical Centres
5.2.1.3. Medical Institutions
5.2.1.4. Diagnostic Laboratories
5.2.1.5. Clinics
5.3. Europe Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Germany Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.2. Germany Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.3. U.K. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.4. U.K. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.5. France Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.6. France Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.7. Italy Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.8. Italy Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.9. Turkey Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.10. Turkey Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.11. Russia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.12. Russia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.13. Rest of Europe Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.14. Rest of Europe Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Hospital Acquired Infection Control Market Outlook, 2019-2032
6.1. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Heat Sterilization Equipment
6.1.1.1.1. Moist Heat Sterilization Equipment
6.1.1.1.2. Dry Heat Sterilization Equipment
6.1.1.2. Low-Temperature Sterilization Equipment
6.1.1.3. Radiation Sterilization Equipment
6.1.1.4. Disinfection Equipment
6.1.1.4.1. Disinfector
6.1.1.4.1.1. Disinfector
6.1.1.4.1.1.1. Washer Disinfector
6.1.1.4.1.1.2. Flusher Disinfector
6.1.1.4.2. Flusher Disinfector
6.1.1.5. Endoscopic Reprocessor Systems
6.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
6.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
6.1.1.6. Disinfectants
6.2. Asia Pacific Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Ambulatory Surgical Centres
6.2.1.3. Medical Institutions
6.2.1.4. Diagnostic Laboratories
6.2.1.5. Clinics
6.3. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. China Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.2. China Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.3. Japan Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.4. Japan Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.5. South Korea Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.6. South Korea Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.7. India Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.8. India Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.9. Southeast Asia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.10. Southeast Asia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.11. Rest of Asia Pacific Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.12. Rest of Asia Pacific Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Hospital Acquired Infection Control Market Outlook, 2019-2032
7.1. Latin America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Heat Sterilization Equipment
7.1.1.1.1. Moist Heat Sterilization Equipment
7.1.1.1.2. Dry Heat Sterilization Equipment
7.1.1.2. Low-Temperature Sterilization Equipment
7.1.1.3. Radiation Sterilization Equipment
7.1.1.4. Disinfection Equipment
7.1.1.4.1. Disinfector
7.1.1.4.1.1. Disinfector
7.1.1.4.1.1.1. Washer Disinfector
7.1.1.4.1.1.2. Flusher Disinfector
7.1.1.4.2. Flusher Disinfector
7.1.1.5. Endoscopic Reprocessor Systems
7.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
7.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
7.1.1.6. Disinfectants
7.2. Latin America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Ambulatory Surgical Centres
7.2.1.3. Medical Institutions
7.2.1.4. Diagnostic Laboratories
7.2.1.5. Clinics
7.3. Latin America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Brazil Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.2. Brazil Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.3. Mexico Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.4. Mexico Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.5. Argentina Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.6. Argentina Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.7. Rest of Latin America Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.8. Rest of Latin America Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Hospital Acquired Infection Control Market Outlook, 2019-2032
8.1. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Heat Sterilization Equipment
8.1.1.1.1. Moist Heat Sterilization Equipment
8.1.1.1.2. Dry Heat Sterilization Equipment
8.1.1.2. Low-Temperature Sterilization Equipment
8.1.1.3. Radiation Sterilization Equipment
8.1.1.4. Disinfection Equipment
8.1.1.4.1. Disinfector
8.1.1.4.1.1. Disinfector
8.1.1.4.1.1.1. Washer Disinfector
8.1.1.4.1.1.2. Flusher Disinfector
8.1.1.4.2. Flusher Disinfector
8.1.1.5. Endoscopic Reprocessor Systems
8.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
8.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
8.1.1.6. Disinfectants
8.2. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Ambulatory Surgical Centres
8.2.1.3. Medical Institutions
8.2.1.4. Diagnostic Laboratories
8.2.1.5. Clinics
8.3. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. GCC Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.2. GCC Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.3. South Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.4. South Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.5. Egypt Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.6. Egypt Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.7. Nigeria Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.8. Nigeria Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.9. Rest of Middle East & Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.10. Rest of Middle East & Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs End User Heatmap
9.2. Manufacturer vs End User Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Olympus Corporation
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Medivators Inc. (Cantel Medical Corp.)
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Getinge Group
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. STERIS Plc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Belimed AG (Metall Zug)
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Steelco S.P.A.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Pfizer Inc.,
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. F. Hoffmann-La Roche Ltd,
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Merck & Co.,
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson),
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Abbott Laboratories
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Bayer AG
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. The 3M Company
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Cepheid Inc.
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. UVision360 Inc.
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations